Add Presentation to Slide Tray Presentation:
Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis: An Update
Clinical Questions Addressed by the CER (2 of 5)
KQ 2 asked: How does fracture reduction resulting from treatments vary between individuals with different risks for fracture as determined by the following factors:
- Bone mineral density
- FRAX or other risk-assessment score
- Prior fractures (prevention vs. treatment)
- Glucocorticoid use
- Other factors (e.g., community dwelling vs. institutionalized, vitamin D deficient vs. not)
Keywords: bone | low bone density | bone density | osteoporosis | fracture | osteopenia | skeletal | FRAX | bone mineral density | glucocorticoid | vitamin D | race | ethnicity
- Newberry SJ, Crandall CC, Gellad WG, et al. Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis: An Update to the 2007 Report. Comparative Effectiveness Review No. 53 (Prepared by the Southern California Evidence-based Practice Center under Contract No. HHSA 290-2007-10062-I). Rockville, MD: Agency for Healthcare Research and Quality; February 2012. AHRQ Publication No. 12-EHC023-EF. Available at www.effectivehealthcare.ahrq.gov/reports/lbd.cfm.
Your slide tray is being processed.